Problem-solving therapy for depression: A meta-analysis

Bell, Alissa C.; D’Zurilla, Thomas J.

doi:10.1016/j.cpr.2009.02.003

Cited by 357 publications

(264 citation statements)

References 28 publications

Supporting

Mentioning

246

Contrasting

Unclassified

Order By: Relevance

“…show promising results in non-psychotic patients (Bell & D'Zurilla, 2009;Raes, Williams, & Hermans, 2009). The use of these approaches could be indicated for people with psychosis too, and could facilitate reductions in positive symptoms as well as in mood disturbance.…”

Section: The Rationale For a Systematic Review Of The Empirical Litermentioning

confidence: 99%

“…Problem solving therapy focuses on training in adaptive problem solving attitudes and skills. A recent meta-analysis of studies with 21 independent samples concluded that problem solving therapy is significantly more effective in reducing depressive symptoms than no treatment or support groups, and equally as effective as other psychological therapies or medication (Bell & D'Zurilla, 2009). …”

Section: Problem Solving Difficultiesmentioning

confidence: 99%

“…There is also some evidence that problem solving therapy (Bell & D'Zurilla, 2009) can lead to improvements in psychotic symptoms (Tarrier et al, 1993), though a specific relationship with persecutory delusions has not been investigated.…”

Section: Problem Solving Difficultiesmentioning

confidence: 99%

See 2 more Smart Citations

Cognitive factors maintaining persecutory delusions in psychosis: The contribution of depression.

Vorontsova¹,

Garety²,

Freeman³

2013

Journal of Abnormal Psychology

View full text Add to dashboard Cite

Depression is common in people with schizophrenia, but how it might directly contribute to the persistence of psychotic symptoms has rarely been tested. The key aim of the present study was to test whether depression and associated cognitive processes predict the maintenance of persecutory delusions. Three groups of participants were tested at baseline: 60 patients with persecutory delusions in the context of a schizophrenia spectrum diagnosis, 30 patients with depression, and 30 nonclinical controls. They completed interviewer and self-report assessments of depression and paranoia, and measures of six cognitive factors (schematic beliefs, experiential avoidance, autobiographical memory, problem solving, rumination, worry style). The patients with persecutory delusions were then assessed again, six months later. It was found that 50% of the patients with persecutory delusions met diagnostic criteria for major depression. Cognitive processes found to be associated with depression across the groups were negative schematic beliefs about the self, experiential avoidance and rumination, but not autobiographical memory or problem solving. The severity of initial depression in patients with persecutory delusions predicted the persistence of paranoia over six months. A number of cognitive factors also predicted the persistence of persecutory delusions, including negative schematic beliefs about the self, worry, and problem-solving difficulties. In conclusion, depression is common in patients with current persecutory delusions, and it shows similar cognitive features to major depressive disorder. The results of this study indicate that depression and related processes may contribute to the maintenance of paranoia. Trials are warranted of depression-related therapeutic techniques for people with persecutory delusions.

show abstract

Section: The Rationale For a Systematic Review Of The Empirical Litermentioning

confidence: 99%

Section: Problem Solving Difficultiesmentioning

confidence: 99%

See 1 more Smart Citation

Cognitive factors maintaining persecutory delusions in psychosis: The contribution of depression.

Vorontsova¹,

Garety²,

Freeman³

2013

Journal of Abnormal Psychology

View full text Add to dashboard Cite

show abstract

“…Les paramètres de résultats examinés ne sont pas présentés de façon détaillée et n'ont pas fait l'objet d'une méta-analyse. Les résultats de la mise à jour réalisée afin de compléter la revue australienne de référence incluaient 12 revues systématiques, y compris les méta-analyses, dont : -2 revues systématiques qui traitent à la fois des troubles dépressifs et des troubles anxieux (Cuijpers et al, 2013 ;Roshanaei-Moghaddam et al, 2011) (Bell & D'Zurilla, 2009 ;Cuijpers, Andersson, Donker, & Van Straten, 2011 ;Cuijpers, Reynolds, et al, 2012 ;Cuijpers, Van Straten, Warmerdam, & Andersson, 2009 ;Gould, Coulson, & Howard, 2012 ;Khan, Faucett, Lichtenberg, Kirsch, & Brown, 2012 ;Spielmans, Berman, & Usitalo, 2011 ;Van Hees, Rotter, Ellermann, & Evers, 2013) incluant environ 138 études avec 18 707 patients ; -et 1 revue systématique qui porte uniquement sur les troubles anxieux (Canton, Scott, & Glue, 2012) incluant 9 ECR totalisant environ 922 patients.…”

Section: Caractéristiques Des éTudes Inclusesunclassified

Efficacité de la psychothérapie comparativement à la pharmacothérapie dans le traitement des troubles anxieux et dépressifs chez l’adulte : une revue de la littérature

Fansi

Jehanno

Lapalme

et al. 2016

smq

View full text Add to dashboard Cite

Dans l’optique de l’amélioration d’une couverture de la psychothérapie au Québec, le ministère de la Santé et des Services sociaux a confié à l’Institut national d’excellence en santé et en services sociaux le mandat d’évaluer l’efficacité de la psychothérapie comparée à la pharmacothérapie dans le traitement des adultes souffrant de troubles anxieux et dépressifs. Une mise à jour d’une revue de la littérature récente et de bonne qualité a été effectuée grâce à une revue des revues systématiques traitant de la psychothérapie comparée à la pharmacothérapie dans le traitement des adultes anxieux et dépressifs avec un horizon temporel compris entre 2009 et 2013. Le niveau de l’ensemble de la preuve scientifique permet de dire que de manière générale, il n’y a pas de différence significative entre la psychothérapie et la pharmacothérapie sur le plan de la réduction des symptômes des patients souffrant de troubles anxieux ou dépressifs modérés, ce qui indique une efficacité comparable de ces deux modes de traitement. Cependant, les avantages de la psychothérapie sont maintenus plus longtemps après la fin du traitement que ceux des médicaments. La psychothérapie offre donc une meilleure protection contre la rechute. Par ailleurs, la combinaison de la psychothérapie et de la pharmacothérapie présente une efficacité supérieure à celle de la psychothérapie seule dans les cas chroniques ou graves.Introduction In Quebec, mental disorders affect one in five people in their lifetime. Anxiety and depressive disorders are the main common or moderate mental health disorders. They affect both the individuals with the disorder and the people around them and have substantial economic impact. Psychotropic drugs are the treatment option most often proposed to patients presenting with moderate mental health disorders. Psychotherapy is nevertheless a treatment that should be given consideration.Physical and financial access to psychotherapy remains limited because only one third of professionals qualified to offer it practise in the public sector, and the coverage and reimbursement policy for this service is very restricted. In order to improve such coverage, the Ministère de la Santé et des Services sociaux (MSSS) mandated the Institut national d’excellence en santé et en services sociaux (INESSS) to assess the evidence on the effectiveness of psychotherapy compared with those of pharmacotherapy for the treatment of adults with anxiety and depressive disorders.Methods An update of a review of recent and good quality literature was conducted through a review of systematic reviews dealing with psychotherapy compared to pharmacotherapy in the treatment of anxiety and depression in adults. The period covered included 2009 to 2013. The literature search strategy, modelled on that of the reference review, was applied to Medline, Cochrane Library, CINAHL, Web of Science and health technology assessment agencies. Exploration of the grey literature focused on information available on the websites of various health assessment organizations.Resu...

show abstract

“…• Guideline 34,35,[47][48][49][50] • Meta-analysis/systematic review [71][72][73][76][77][78]83,84 • RCT 70,75,[79][80][81][82][85][86][87] • Quasi/nonexperimental 74 QI 5: Treatment initiation (antidepressant medication or psychotherapy).…”

Section: Guideline Recommendationsmentioning

confidence: 99%

Evidence for the Management of Adolescent Depression

et al. 2013

View full text Add to dashboard Cite

Adolescent depression is a prevalent and disabling condition resulting in emotional suffering and social and educational dysfunction. Care for adolescent depression is suboptimal and could be improved through the development and use of quality indicators (QIs). This article reports on the development of a care pathway and QIs for the primary and specialty care management of adolescent depression from case identification through symptom remission. It presents evidence from a review of adolescent clinical practice guidelines and research literature to support QIs at critical nodes in the pathway, and describes implications for practice based on existing evidence. Barriers to measure development are identified, including gaps in empirical evidence, and a research agenda is suggested. Pediatrics 2013;132:e996-e1009

show abstract

Problem-solving therapy for depression: A meta-analysis

Cited by 357 publications

References 28 publications

Cognitive factors maintaining persecutory delusions in psychosis: The contribution of depression.

Cognitive factors maintaining persecutory delusions in psychosis: The contribution of depression.

Efficacité de la psychothérapie comparativement à la pharmacothérapie dans le traitement des troubles anxieux et dépressifs chez l’adulte : une revue de la littérature

Evidence for the Management of Adolescent Depression

Contact Info

Product

Resources

About